Obesity market research reports by Roots Analysis

Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035

Jan 22, 2025  |  Published by: Roots Analysis  |  USD 4,799

ANTI-OBESITY DRUGS MARKET As per Roots Analysis, the global anti-obesity drugs market size is estimated to grow from USD 12. 8 billion in the current year to USD 104. 9 billion by 2035, at a CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been ... Read More